BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15243841)

  • 21. Mammography perceptions and practices among women aged 30-49: The role of screening programme availability and cultural affiliation.
    Labrie NHM; Ludolph RA; Schulz PJ
    Patient Educ Couns; 2020 Feb; 103(2):369-375. PubMed ID: 31506173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Swiss Medical Board Mammography screening predictions for Switzerland: importance of time-periods.
    de Koning HJ; Heijnsdijk EA
    J Med Screen; 2015 Dec; 22(4):201-6. PubMed ID: 26018779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast cancer screening in 21 countries: delivery of services, notification of results and outcomes ascertainment.
    Ballard-Barbash R; Klabunde C; Paci E; Broeders M; Coleman EA; Fracheboud J; Bouchard F; Rennert G; Shapiro S
    Eur J Cancer Prev; 1999 Oct; 8(5):417-26. PubMed ID: 10548397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The attendance of the first screening round (2002-2003) of the Hungarian organized breast cancer screening program and its effect on the number of diagnostic and screening mammography].
    Boncz I; Sebestyén A; Döbrossy L; Péntek Z; Kovács A; Csaba D; Budai A; Ember I
    Orv Hetil; 2005 Sep; 146(38):1963-70. PubMed ID: 16238249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening mammography and public health policy: the need for perspective.
    Wright CJ; Mueller CB
    Lancet; 1995 Jul; 346(8966):29-32. PubMed ID: 7603143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveys on mammography frequency in Geneva.
    Lutz JM; Reith-Chaton J; Fioretta G; Cerny V; Bouchardy C
    J Med Screen; 2000; 7(2):111-3. PubMed ID: 11002453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of a subsidised mammographic screening programme in Malaysia, a middle-income Asian country.
    Lee M; Mariapun S; Rajaram N; Teo SH; Yip CH
    BMC Public Health; 2017 Jan; 17(1):127. PubMed ID: 28129762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mammography requests in general practice during the introduction of nationwide breast cancer screening, 1988-1995.
    Beemsterboer PM; de Koning HJ; Looman CW; Borsboom GJ; Bartelds AI; van der Maas PJ
    Eur J Cancer; 1999 Mar; 35(3):450-4. PubMed ID: 10448298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening is associated with lower mastectomy rates in eastern Switzerland beyond stage effects.
    Herrmann C; Morant R; Walser E; Mousavi M; Thürlimann B
    BMC Cancer; 2021 Mar; 21(1):229. PubMed ID: 33676446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer stage at diagnosis and geographic access to mammography screening (New Hampshire, 1998-2004).
    Celaya MO; Berke EM; Onega TL; Gui J; Riddle BL; Cherala SS; Rees JR
    Rural Remote Health; 2010; 10(2):1361. PubMed ID: 20438282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do nonattenders in mammography screening programmes seek mammography elsewhere?
    Jensen A; Olsen AH; von Euler-Chelpin M; Helle Njor S; Vejborg I; Lynge E
    Int J Cancer; 2005 Jan; 113(3):464-70. PubMed ID: 15455383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of depression on adherence to organized and opportunistic breast cancer screening.
    Montagna G; Schneeberger AR; Rossi L; Reina H; Schwab FD; Schoetzau A; Eichholzer M; Pagani O; Weber WP; Kurzeder C; Güth U; Huber CG
    Eur J Cancer Prev; 2020 Jan; 29(1):53-59. PubMed ID: 30998527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results from the Swiss mammography screening pilot programme.
    Bulliard JL; De Landtsheer JP; Levi F
    Eur J Cancer; 2003 Aug; 39(12):1761-9. PubMed ID: 12888372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors.
    Neeser K; Szucs T; Bulliard JL; Bachmann G; Schramm W
    Value Health; 2007; 10(1):42-53. PubMed ID: 17261115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mammography screening in Italy: 2004 survey and 2005 preliminary data.
    Giorgi D; Giordano L; Ventura L; Frigerio A; Paci E; Zappa M
    Epidemiol Prev; 2007; 31(2-3 Suppl 2):7-20. PubMed ID: 17824359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Organised mammography screening reduces breast cancer mortality: a cohort study from Finland.
    Sarkeala T; Heinävaara S; Anttila A
    Int J Cancer; 2008 Feb; 122(3):614-9. PubMed ID: 17847022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Women's perception of the benefits of mammography screening: population-based survey in four countries.
    Domenighetti G; D'Avanzo B; Egger M; Berrino F; Perneger T; Mosconi P; Zwahlen M
    Int J Epidemiol; 2003 Oct; 32(5):816-21. PubMed ID: 14559757
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.